Singapore markets closed

Global Medical REIT Inc. (GMRE-PA)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
24.21-0.12 (-0.49%)
At close: 03:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.15
52-week change 3-3.87%
S&P500 52-week change 324.19%
52-week high 325.72
52-week low 323.32
50-day moving average 324.85
200-day moving average 324.77

Share statistics

Avg vol (3-month) 35.73k
Avg vol (10-day) 36.25k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 861.79M
% held by insiders 10.00%
% held by institutions 119.21%
Shares short (15 Apr 2024) 432
Short ratio (15 Apr 2024) 40.19
Short % of float (15 Apr 2024) 4N/A
Short % of shares outstanding (15 Apr 2024) 4N/A
Shares short (prior month 15 Mar 2024) 4931

Dividends & splits

Forward annual dividend rate 41.88
Forward annual dividend yield 47.71%
Trailing annual dividend rate 30.21
Trailing annual dividend yield 30.86%
5-year average dividend yield 47.32
Payout ratio 4N/A
Dividend date 330 Apr 2024
Ex-dividend date 412 Apr 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 14.61%
Operating margin (ttm)25.49%

Management effectiveness

Return on assets (ttm)1.78%
Return on equity (ttm)3.46%

Income statement

Revenue (ttm)141.05M
Revenue per share (ttm)2.15
Quarterly revenue growth (yoy)-9.20%
Gross profit (ttm)N/A
EBITDA 91.86M
Net income avi to common (ttm)14.79M
Diluted EPS (ttm)0.20
Quarterly earnings growth (yoy)-66.20%

Balance sheet

Total cash (mrq)26.4M
Total cash per share (mrq)0.4
Total debt (mrq)618.91M
Total debt/equity (mrq)102.16%
Current ratio (mrq)2.25
Book value per share (mrq)7.76

Cash flow statement

Operating cash flow (ttm)68.44M
Levered free cash flow (ttm)85.63M